Journal of Hebei Medical University

Previous Articles     Next Articles

Effect of raltitrexed combined oxaliplantin as secondline chemotherapy for advanced gastric cardial carcinoma

  

  1. (1.Fifth Department of Thoracic Surgery,the Fourth Hospital of Hebei Medical University,
    Shijiazhuang 050091,China;2.Department of Cadre Ward,the Third Hospital of Hebei Medical University,Shijiazhuang,050011,China
  • Online:2016-01-25 Published:2016-04-27

Abstract:  Objective Toevaluatetheefficiency andtoxicity ofraltitrexedcombined
qxaliplantinassecond-linechemotherapyintreatmentofadvancedgastriccardialcarcinoma.
Methods Fifty-eightpatientsofadvancedgastriccardialcarcinomawhohadreceivedfirst-line
therapybuthadrelapsedorprogressedweregiven3mg
/ m
2 ofraltitrexed ,
intravenousbolus ,
d1 , 21daysasacycle , combinedoxaliplantin130mg / m
2 ,
intravenousinfusion>3h , d1 , 21
daysasacycle.Theanalysislastedatleasttwocyclessoastoevaluatetheshort-termefficiency
andadversereactions.Aftertwocyclesofchemotherapy , theefficiencyandtoxicity were
evaluated.Atotalofsixcycleswereappliedunlesstherewereevidenceofdiseaseprogressionor
intoleranceoftreatment.Results All58patientswereevaluable , includingcompleteresponse2
cases , accountingfor3.4% , partialresponse16cases , accountingfor27.6% ; stabledisease14
cases , accountingfor24.1% ; progressivedisease26cases , 44.8%.Overallresponseratewas
31.0% , diseasecontrolrate55.2% , themiddletimetoprogression6.9months.Themainside
effects were myelosuppression , gastrointestinal reactions , aminotransferase abnormality ,
peripheralneurotoxicityandsoon.Thewholegrouphadnotreatment-relateddeathinpatients
and no toxicity due to the delay chemotherapy.Conclusion Raltitrexed as second-line chemotherapyintreatmentofadvancedgastriccardialcarcinomaiseffectiveandwelltolerated.

Key words: stomach neoplasms, antineoplastic combined chemotherapy protocols, treatment outcome